Back to Clinical Trials Overview
Back To Cancer Clinical Trials
A Randomized, Open-label, Multicenter, Phase III Study to Compare the Efficacy and Safety of Eribulin with Dacarbazine in Subjects with Soft Tissue Sarcoma
Principal Investigator(s): Robert G. Maki
A Phase III Randomized Trial of Adding Vincristine-topotecan- cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-metastatic Ewing Sarcoma
Principal Investigator(s): Birte Wistinghausen
Vincritine, Dactinomycin and Cyclophosphomaide for Rhabdomyosarcoma (Sarcoma)
Principal Investigator(s): Birte Wistinghausen
ARST0332: Risk-Based Treatment for Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS)
Principal Investigator(s): Birte Wistinghausen
ARST0531 - Randomized Study of Vincristine, Dactinomycin and Cyclophosphamide (VAC) versus VAC alternating with Vincristine and Irinotecan Hydrochloride in Combination With Radiotherapy for Patients with Intermediate Risk Rhabdomyosarcoma( RMS)
Principal Investigator(s): Birte Wistinghausen
Back To Cancer Clinical Trials
Your search for "Sarcoma and Soft Tissue" returned 5 results:
A Randomized, Open-label, Multicenter, Phase III Study to Compare the Efficacy and Safety of Eribulin with Dacarbazine in Subjects with Soft Tissue Sarcoma
Principal Investigator(s): Robert G. Maki
A Phase III Randomized Trial of Adding Vincristine-topotecan- cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-metastatic Ewing Sarcoma
Principal Investigator(s): Birte Wistinghausen
Vincritine, Dactinomycin and Cyclophosphomaide for Rhabdomyosarcoma (Sarcoma)
Principal Investigator(s): Birte Wistinghausen
ARST0332: Risk-Based Treatment for Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS)
Principal Investigator(s): Birte Wistinghausen
ARST0531 - Randomized Study of Vincristine, Dactinomycin and Cyclophosphamide (VAC) versus VAC alternating with Vincristine and Irinotecan Hydrochloride in Combination With Radiotherapy for Patients with Intermediate Risk Rhabdomyosarcoma( RMS)
Principal Investigator(s): Birte Wistinghausen
Contact Us
Office of Research Services (ORS)
Tel: 212-824-7294
Send e-mail
Related Resources
For Patients
- Find a Mount Sinai Doctor
- Find a Mount Sinai Department or Institute
- Research Match
- Clinicaltrials.gov
- National Cancer Clinical Trials
- Video - Participating in Research - You Can Be Part of the Answer
- The Center for Information & Study on Clinical Research Participation
- Patients Like Me
For Investigators
- Office of Research Services (ORS)
- How to Post Research Projects on the Website
- Conduits
- Research Information Technology
- Communicating with Research Subjects